BioVie to present Long COVID and Parkinson’s trial results at American Neurological Association meeting

BioVie Inc (NASDAQ:BIVI, NASDAQ:BIVIW) will present results from two Phase 2 trials of its experimental drug bezisterim, in Long COVID and Parkinson’s disease, at the American Neurological Association’s annual meeting in San Diego. The company said both abstracts were accepted as poster...